Browse studies

Find your next paid study

27,333 recruiting studies available now

Stories to Prevent (StoP) HPV Cancers: A Communication Intervention to Increase HPV Vaccination Among Diverse Populations.

This randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates amon…

Human Papillomavirus VaccinationEmotions

Estimated

~$10 – $750

Actual pay is set by the research site.

Milton S. Hershey Medical CenterNCT06808776

Longitudinal Study of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Post-Acute Sequelae of COVID-19 (PASC)

This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect in…

SARS CoV-2 Post-Acute Sequelae

Estimated

~$10 – $750

Actual pay is set by the research site.

University of North Carolina, Chapel HillNCT07781501

Observational

Digital Habit and Neural Indicators of Well-Being

Social media apps are designed to make opening and continuing to use them easy, which may contribute to habitual or unwanted use. This study will test whether …

Social MediaDigital Well-being

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Southern CaliforniaNCT07829211

Phase 3

A 52-week Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy and Safety of Remibrutinib (LOU064) in Adult and Adolescent Participants With IgE-mediated Food Allergy

The purpose of this Phase III study is to evaluate the clinical efficacy and safety of remibrutinib in participants with peanut, or cow's milk ("milk", cooked …

IgE-Mediated Food AllergyPeanut AllergyCow Milk Allergy+1 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07768371

Phase 2

Analgesic Requirement for Post-Operative Pain Control in Elective 1-3 Level Transforaminal Lumbar Interbody Fusion: Comparison of Thoracolumbar Interfascial Plane Block With Exparel to Bupivacaine HCl

The goal of this clinical trail is to to compare the efficacy of thoracolumbar interfascial plane block with Exparel vs with standard of care 0.25% Bupivacaine…

Back PainSurgery-ComplicationsNarcotic Use+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Foundation for Orthopaedic Research and EducationNCT06350981

Phase 4

A Randomized Controlled Trial Comparing Renal Effects of Vancomycin Combined With Either Piperacillin/Tazobactam or Meropenem: VPT Patient Safety (VPS) Study

The VPT Safety Trial (VPS) compares two common antibiotic combinations to see how they affect the kidneys of patients in the hospital with serious infections. …

InfectionAcute Kidney InjurySepsis

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Bassett HealthcareNCT07556107

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

To learn if drawing blood directly from veins inside the brain is safe and can effectively provide the same kind of detailed information about high-grade gliom…

Intracranial Venous BloodBrain CancersLiquid Biopsy+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07467109

Phase 3

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting wo…

Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06966700

Phase 1

Adaptive Radiation for Abdominopelvic Metastases (ARAM)

Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. Adaptive SBRT will allow for escalation of the prescript…

Neoplasm - Soft Tissue Pelvis Malignant SecondaryMalignant Neoplasm of Stomach

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Fox Chase Cancer CenterNCT05880667

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subj…

Vascular DiseaseDissectionDissection Aortic Aneurysm+5 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

W.L.Gore & AssociatesNCT06658730

Phase 1

Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

The main goals of this clinical trial are to find out what the best dose of the study drug, OTP-01, is for patients with solid tumors through understanding how…

Advanced Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ottimo Pharma LimitedNCT07266428

Phase 1

A Phase 1, First-in-Human Study of CUSP06, a Cadherin-6 (CDH6)-Directed Antibody-Drug Conjugate, in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

This phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian canc…

Ovarian CancerSolid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

OnCusp Therapeutics, Inc.NCT06234423